PAR-24-279 - Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 3

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Accelerating Research in Understudied Skin Types NOT-AR-24-009 NIAMS Jul 31, 2023 Jul 17, 2026 R21, R01, R34
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening NOT-OD-22-179 ODP , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO Jul 14, 2022 May 8, 2025 R21, R01, R61/R33, UG3/UH3, R34, U01
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening NOT-OD-22-107 ODP , NIA , NIAAA , NIAMS , NICHD , NIDA , NIDCD , NIDCR , NIMH , NIMHD , NINDS , NINR , ODS , ORWH , SGMRO May 12, 2022 May 8, 2025 333, R01, R34, R21, R61/R33, U01, UG3/UH3

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
For technical issues E-mail OER Webmaster